Skip to content

    Advisory Panel Votes Against Drug's Approval Because of Potential Side Effects

    July 15, 2010 -- Don't approve Qnexa for weight loss, an FDA expert advisory panel today said in a 10-6 vote.

    The panel of medical experts found Qnexa effective but worried about millions taking it before safety concerns are answered.

    The FDA usually follows the recommendation of its advisory panel, but the split vote, and some of the comments by panelists, may leave the FDA room to approve the drug.

    "I hope my 'no' vote will allow more discussion. I would not be upset if it were approved with more indications [limiting its use]," said panel chair Kenneth Burman, MD, of Georgetown University.

    With the rest of the panel, Burman agreed that Qnexa works better than any approved weight loss drug. While people taking it don't get thin, they do lose 6% to 10% of their body weight -- if they also undergo a program of diet and exercise.

    But the drug has side effects, both known and theoretical. It may cause birth defects, it may increase suicide risk, it can cause a condition called metabolic acidosis that speeds bone loss, it increases risk of kidney stones, and may have other serious effects.

    "It is difficult if not impossible to weigh these issues as the clinical trials went on only for a year, and patients will use this drug for lifetime," Burman said. "It is impossible to extrapolate the trial data to the wider population."

    Even so, the FDA was listening to Burman and other panelists who said their vote against approval was a close call.

    "When you listen to even the 'no' voters, you got the sense a lot of people had a little bit of hesitancy," FDA Deputy Director for Endocrine Products Eric C. Colman, MD, said in a news conference. "They were not strongly against the drug but had lingering concerns that made them vote 'no.'"

    Potential for Widespread Use

    Qnexa is a combination of low doses of two drugs already on the market: the amphetaminephentermine and the seizure drug topiramate.

    It's targeted for use only by obese patients and in overweight people with a BMI of 27 or more plus a weight-associated condition such as high cholesterol, type 2 diabetes, or high blood pressure. But panelists worried that millions of people struggling with their weight will want to give the drug a try.

    Healthy Recipe Finder

    Browse our collection of healthy, delicious recipes, from WebMD and Eating Well magazine.

    Top searches: Chicken, Chocolate, Salad, Desserts, Soup

    Heart Rate Calculator

    Ensure you're exercising hard enough to get a good workout, but not strain your heart.

    While you are exercising, you should count between...